Baxter's platform for home dialysis wins Chicago Innovation Award

  • Baxter's AMIA APD with ShareSource telehealth platform was recognized as a winner of the 15th Annual Chicago Innovation Awards.

    Baxter's AMIA APD with ShareSource telehealth platform was recognized as a winner of the 15th Annual Chicago Innovation Awards.

 
Business Wire
Updated 10/26/2016 9:42 AM

DEERFIELD -- Baxter International was named a winner of the 15th annual Chicago Innovation Awards for its recently launched AMIA automated peritoneal dialysis system with ShareSource remote patient management platform.

This year's awards were presented at the Harris Theater in Chicago on Oct. 25, recognizing the top innovations out of a record-setting 643 submissions by regionally headquartered companies or civic groups.

                                                                                                                                                                                                                       
 

Baxter's AMIA APD with ShareSource, a two-way, cloud-based telehealth platform, is designed to advance home peritoneal dialysis therapy. AMIA with ShareSource is the first and only APD medical device to include patient-centric features that help guide end-stage renal disease patients through their home PD therapy, while allowing their health care providers to remotely view and manage their therapy.

"It's an honor for Baxter's AMIA with ShareSource system to be recognized as a top innovation in Chicago -- a city with a rich and diverse history of bringing unique solutions to market that enrich lives," said Giuseppe Accogli, corporate vice president and president for Baxter Renal. "AMIA with ShareSource is uniquely designed to help support what was an unmet need for more intuitive technology that helps more patients self-administer PD therapy, which is evident in the quick adoption of the system by U.S. health care providers and dialysis patients."

0 Comments
                                                                                                                                                                                                                       
 
Article Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.